Retrospective Spatio-Temporal Dynamics of Dengue Virus 1, 2 and 4 in Paraguay.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
30 05 2023
Historique:
received: 13 04 2023
revised: 06 05 2023
accepted: 08 05 2023
medline: 29 6 2023
pubmed: 28 6 2023
entrez: 28 6 2023
Statut: epublish

Résumé

Dengue virus (DENV) has been a major public health concern in Paraguay, with frequent outbreaks occurring since early 1988. Although control measures have been implemented, dengue remains a significant health threat in the country, and continued efforts are required for prevention and control. In response to that, in collaboration with the Central Public Health Laboratory in Asunción, we conducted a portable whole-genome sequencing and phylodynamic analysis to investigate DENV viral strains circulating in Paraguay over the past epidemics. Our genomic surveillance activities revealed the co-circulation of multiple DENV serotypes: DENV-1 genotype V, the emerging DENV-2 genotype III, BR4-L2 clade, and DENV-4 genotype II. Results additionally highlight the possible role of Brazil as a source for the international dispersion of different viral strains to other countries in the Americas emphasizing the need for increased surveillance across the borders, for the early detection and response to outbreaks. This, in turn, emphasizes the critical role of genomic surveillance in monitoring and understanding arbovirus transmission and persistence locally and over long distances.

Identifiants

pubmed: 37376575
pii: v15061275
doi: 10.3390/v15061275
pmc: PMC10304136
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : U01 AI151698
Pays : United States

Références

Nat Commun. 2021 Apr 16;12(1):2296
pubmed: 33863880
Proc Natl Acad Sci U S A. 2012 Sep 11;109(37):15066-71
pubmed: 22927414
Bioinformatics. 2014 Nov 15;30(22):3276-8
pubmed: 25095880
Emerg Infect Dis. 2007 May;13(5):764-7
pubmed: 17553261
Mol Biol Evol. 2013 Feb;30(2):239-43
pubmed: 23090976
Emerg Infect Dis. 2008 Aug;14(8):1232-9
pubmed: 18680646
Nat Protoc. 2017 Jun;12(6):1261-1276
pubmed: 28538739
Bioinformatics. 2019 Mar 1;35(5):871-873
pubmed: 30124794
Mol Biol Evol. 2010 Aug;27(8):1877-85
pubmed: 20203288
Emerg Infect Dis. 2021 May;27(5):1393-1404
pubmed: 33900172
Mol Biol Evol. 2015 Jan;32(1):268-74
pubmed: 25371430
Bioinformatics. 2016 Oct 15;32(20):3204-3206
pubmed: 27334476
Mol Biol Evol. 2021 Jul 29;38(8):3486-3493
pubmed: 33528560
Virus Evol. 2018 Jun 08;4(1):vey016
pubmed: 29942656
Int J Environ Res Public Health. 2022 Sep 26;19(19):
pubmed: 36231491
PLoS Negl Trop Dis. 2019 May 8;13(5):e0007231
pubmed: 31067235
PLoS Negl Trop Dis. 2013 Jul 11;7(7):e2311
pubmed: 23875046
Virus Evol. 2016 Apr 09;2(1):vew007
pubmed: 27774300
Brief Bioinform. 2019 Jul 19;20(4):1160-1166
pubmed: 28968734
Sci Data. 2023 May 12;10(1):275
pubmed: 37173303
Nat Rev Genet. 2018 Jan;19(1):9-20
pubmed: 29129921

Auteurs

Cynthia Vazquez (C)

Laboratorio Central de Salud Pública, Asunción 001535, Paraguay.

Luiz Carlos Junior Alcantara (LCJ)

Instituto Rene Rachou, Fundação Oswaldo Cruz, Belo Horizonte 30190-002, MG, Brazil.

Vagner Fonseca (V)

Organização Pan-Americana da Saúde, Organização Mundial da Saúde, Brasília 70-800400, SP, Brazil.

Mauricio Lima (M)

Instituto Rene Rachou, Fundação Oswaldo Cruz, Belo Horizonte 30190-002, MG, Brazil.
Laboratorio Central de Saúde Pública do Estado de Minas Gerais, Fundação Ezequiel Dias, Belo Horizonte 30510-010, MG, Brazil.

Joilson Xavier (J)

Instituto Rene Rachou, Fundação Oswaldo Cruz, Belo Horizonte 30190-002, MG, Brazil.
Laboratorio Central de Saúde Pública do Estado de Minas Gerais, Fundação Ezequiel Dias, Belo Horizonte 30510-010, MG, Brazil.

Talita Adelino (T)

Laboratorio Central de Saúde Pública do Estado de Minas Gerais, Fundação Ezequiel Dias, Belo Horizonte 30510-010, MG, Brazil.

Hegger Fritsch (H)

Instituto Rene Rachou, Fundação Oswaldo Cruz, Belo Horizonte 30190-002, MG, Brazil.
Laboratorio Central de Saúde Pública do Estado de Minas Gerais, Fundação Ezequiel Dias, Belo Horizonte 30510-010, MG, Brazil.

Emerson Castro (E)

Laboratorio Central de Saúde Pública do Estado de Minas Gerais, Fundação Ezequiel Dias, Belo Horizonte 30510-010, MG, Brazil.

Carla de Oliveira (C)

Laboratório de Arbovírus e Vírus Hemorrágicos (LARBOH), Instituto Osawldo Cruz, Fiocruz, Rio de Janeiro 21040-900, RJ, Brazil.

Gabriel Schuab (G)

Laboratório de Arbovírus e Vírus Hemorrágicos (LARBOH), Instituto Osawldo Cruz, Fiocruz, Rio de Janeiro 21040-900, RJ, Brazil.

Alex Ranieri Jerônimo Lima (ARJ)

Butantan Institute, Center for Viral Surveillance and Serological Assessment (CeVIVAS), Sao Paulo 05507-000, SP, Brazil.

Shirley Villalba (S)

Laboratorio Central de Salud Pública, Asunción 001535, Paraguay.

Andrea Gomez de la Fuente (A)

Laboratorio Central de Salud Pública, Asunción 001535, Paraguay.

Analia Rojas (A)

Laboratorio Central de Salud Pública, Asunción 001535, Paraguay.

Cesar Cantero (C)

Laboratorio Central de Salud Pública, Asunción 001535, Paraguay.

Fatima Fleitas (F)

Laboratorio Central de Salud Pública, Asunción 001535, Paraguay.

Carolina Aquino (C)

Laboratorio Central de Salud Pública, Asunción 001535, Paraguay.

Andrea Ojeda (A)

Dirección General de Vigilancia de la Salud, Asunción 40556, Paraguay.

Guillermo Sequera (G)

Dirección General de Vigilancia de la Salud, Asunción 40556, Paraguay.

Juan Torales (J)

Laboratorio Central de Salud Pública, Asunción 001535, Paraguay.

Julio Barrios (J)

Laboratorio Central de Salud Pública, Asunción 001535, Paraguay.

Maria Carolina Elias (MC)

Butantan Institute, Center for Viral Surveillance and Serological Assessment (CeVIVAS), Sao Paulo 05507-000, SP, Brazil.

Felipe C M Iani (FCM)

Laboratorio Central de Saúde Pública do Estado de Minas Gerais, Fundação Ezequiel Dias, Belo Horizonte 30510-010, MG, Brazil.

Maria Jose Ortega (MJ)

Laboratorio Central de Salud Pública, Asunción 001535, Paraguay.

Maria Liz Gamarra (ML)

Laboratorio Central de Salud Pública, Asunción 001535, Paraguay.

Romeo Montoya (R)

Enfermedades Trasmisibles y Determinantes Ambientales de la Salud CDE/HA/PHE, OPS/OMS, Asuncion 40126, Paraguay.

Evandra Strazza Rodrigues (ES)

Blood Center of Ribeirão Preto, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14051-140, SP, Brazil.

Simone Kashima (S)

Blood Center of Ribeirão Preto, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14051-140, SP, Brazil.

Sandra Coccuzzo Sampaio (SC)

Butantan Institute, Center for Viral Surveillance and Serological Assessment (CeVIVAS), Sao Paulo 05507-000, SP, Brazil.

Norma Coluchi (N)

Laboratorio Central de Salud Pública, Asunción 001535, Paraguay.

Juliana Leite (J)

Emergency Department, Infectious Hazards Management, Pan American Health Organization, Washington, DC 20037, USA.

Lionel Gresh (L)

Emergency Department, Infectious Hazards Management, Pan American Health Organization, Washington, DC 20037, USA.

Leticia Franco (L)

Emergency Department, Infectious Hazards Management, Pan American Health Organization, Washington, DC 20037, USA.

José Lourenço (J)

Biosystems and Integrative Sciences Institute, Faculty of Sciences, University of Lisbon, 1749-016 Lisbon, Portugal.

Jairo Mendez Rico (JM)

Emergency Department, Infectious Hazards Management, Pan American Health Organization, Washington, DC 20037, USA.

Ana Maria Bispo de Filippis (AM)

Laboratório de Arbovírus e Vírus Hemorrágicos (LARBOH), Instituto Osawldo Cruz, Fiocruz, Rio de Janeiro 21040-900, RJ, Brazil.

Marta Giovanetti (M)

Instituto Rene Rachou, Fundação Oswaldo Cruz, Belo Horizonte 30190-002, MG, Brazil.
Sciences and Technologies for Sustainable Development and One Health, University of Campus Bio-Medico, 00128 Rome, Italy.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH